Showing 41 - 50 of 56 posts
https://www.coltonconsortium.org/publications/trajectory-of-beta-cell-function-and-insulin-clearance-in-stage-2-type-1-diabetes-natural-history-and-response-to-teplizumab/
https://www.coltonconsortium.org/publications/risk-of-relapse-of-antineutrophil-cytoplasmic-antibody-associated-vasculitis-in-a-randomized-controlled-trial-of-plasma-exchange-and-glucocorticoids/
https://www.coltonconsortium.org/publications/safety-and-efficacy-of-evobrutinib-in-relapsing-multiple-sclerosis-evolutionrms1-and-evolutionrms2-two-multicentre-randomised-double-blind-active-controlled-phase-3-trials/
https://www.coltonconsortium.org/publications/safety-and-tolerability-of-conversion-to-siponimod-from-other-disease-modifying-therapies-in-patients-with-advancing-forms-of-relapsing-ms-results-from-the-exchange-study/
https://www.coltonconsortium.org/publications/short-and-long-term-effects-of-early-versus-delayed-treatment-with-ocrelizumab-on-cerebellar-volume-loss-in-patients-with-rms-and-ppms/
https://www.coltonconsortium.org/publications/teplizumab-induces-persistent-changes-in-the-antigen-specific-repertoire-in-individuals-at-risk-for-type-1-diabetes/
https://www.coltonconsortium.org/publications/crizanlizumab-for-retinal-vasculopathy-with-cerebral-leukoencephalopathy-in-a-phase-ii-clinical-study/
https://www.coltonconsortium.org/publications/effect-of-bimekizumab-on-patient-reported-disease-impact-in-patients-with-psoriatic-arthritis-1-year-results-from-two-phase-3-studies/
https://www.coltonconsortium.org/publications/efficacy-and-safety-of-avacopan-in-patients-aged-65-years-and-older-with-anca-associated-vasculitis-a-post-hoc-analysis-of-data-from-the-advocate-trial/
https://www.coltonconsortium.org/publications/a-phase-3-trial-of-upadacitinib-for-giant-cell-arteritis/
